Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adenocarcinoma Risk Factors
Data on adenocarcinoma risk factors discussed by researchers at Rouen University
April 6th, 2008
Investigators publish new data in the report 'Adenocarcinoma of Ethmoid: a GETTEC retrospective multicenter study of 418 cases.' According to a study from Rouen, France, "To determine risk factors and evaluate the treatment of ethmoid adenocarcinoma. Epidemiologic data were recorded and compared with the literature." "A multicenter and retrospective study. The medical records of 418 patients who had presented with ethmoid adenocarcinoma at 11 French hospitals from 1976 to 2001 were analyzed to determine the clinical characteristics and treatment of the disease. The gender ratio was 2.8 men per 1 woman. Toxic exposure was classic for this lesion, exposure to wood and...
Source: Pharma Investments, Ventures & Law Weekly (2008-04-06)
|
